Skip to main content
. 2018 Apr 4;9:215. doi: 10.3389/fneur.2018.00215

Table 1.

Participant demographics.

Parkinson’s disease HC
n 39 20
Age (years) 68.7 (8.0) 71.4 (8.1)
Sex (M/F) 26/13 7/13
Disease duration (years) 7.1 (5.7)
MDS-UPDRS III 40.1 (13.6)
PIGD 5.5 (3.5)
Hoehn and Yahr 2.4 (0.6)
MoCA 24.4 (4.1) 27.1 (1.9)
Levodopa equivalent dose (mg) 1,024 (75–8,680)